Retour sur lavenir.net
   NYXOAH 2.330 € (-4,90 %)     CIE BOIS SAUVAGE 316.000 € (+0,96 %)     KBC 114.800 € (+1,95 %)     SOFINA 228.000 € (+1,88 %)     AB INBEV 71.840 € (-0,08 %)     TINC 11.940 € (-2,77 %)     COLRUYT 33.060 € (-1,20 %)     GIMV 49.900 € (+0,81 %)     SOLVAY 26.220 € (+0,85 %)     SIPEF 95.500 € (+0,32 %)     UCB 243.900 € (+0,79 %)     EVS BROADC.EQUIPM. 31.900 € (+2,41 %)     PROXIMUS 6.890 € (-0,14 %)     BREDERODE 102.400 € (+0,59 %)     MELEXIS 82.000 € (+0,68 %)     BANQUP GROUP 2.190 € (-10,61 %)     SHURGARD 23.800 € (-0,42 %)     KBC ANCORA 81.100 € (+2,40 %)     TUBIZE-FIN 210.800 € (+1,44 %)     KINEPOLIS GROUP 29.700 € (+1,37 %)     CAMPINE 238.000 € (+3,03 %)     CENERGY 25.460 € (+6,00 %)     ASCENCIO 50.400 € (+0,90 %)     UMICORE 25.960 € (-0,84 %)     ONWARD MEDICAL 2.910 € (+2,83 %)     HOME INVEST BE. 19.280 € (+1,80 %)     FAGRON 25.150 € (+0,60 %)     D'IETEREN GROUP 171.800 € (+2,57 %)     TITAN S.A. 48.020 € (+0,33 %)     ELIA GROUP 139.700 € (+1,53 %)     AEDIFICA 71.700 € (+0,21 %)     GBL 81.900 € (+1,11 %)     ARGENX SE 697.800 € (-0,46 %)     ACKERMANS V.HAAREN 279.600 € (+2,04 %)     BPOST 1.800 € (+1,81 %)     VAN DE VELDE 30.300 € (-1,30 %)     FLUXYS BELGIUM D 20.000 € (+0,76 %)     VGP 81.000 € (+0,87 %)     INCLUSIO SA/NV 17.200 € (+4,88 %)     TESSENDERLO 21.350 € (-0,23 %)     DEME GROUP 188.600 € (+0,86 %)     SYENSQO 66.800 € (+0,45 %)     RECTICEL 10.820 € (+0,93 %)     XIOR 27.550 € (+0,92 %)     AZELIS GROUP 10.250 € (-0,58 %)     CELYAD ONCOLOGY 0.288 € (-0,69 %)     CMB.TECH 14.500 € (-0,55 %)     AGEAS 68.300 € (+0,29 %)     QRF 11.500 € (-1,29 %)     MONTEA 68.100 € (+1,64 %)     WDP 22.260 € (+1,09 %)     ONTEX GROUP 2.670 € (+0,38 %)     CARE PROPERTY INV. 13.240 € (+0,46 %)     VIOHALCO 19.560 € (+2,62 %)     EXMAR 11.600 € (-0,43 %)     JENSEN-GROUP 77.000 € (+0,79 %)     BEKAERT 41.750 € (+0,72 %)     DECEUNINCK 2.095 € (+1,70 %)     HYBRID SOFTWARE GR 4.140 € (+0,49 %)     IBA 15.620 € (+1,56 %)  
   PLANISWARE 18.760 € (+0,75 %)     VIRIDIEN 114.100 € (-0,95 %)     MAUNA KEA TECH 0.180 € (+2,04 %)     CVC CAPITAL 13.330 € (+2,22 %)     ONE EXPERIENCE 0.339 € (+0,89 %)     ASML HOLDING 1 418.600 € (+0,68 %)     PROSUS 40.905 € (+4,72 %)     VOPAK 47.300 € (+1,72 %)     AIRBUS 174.400 € (+2,88 %)     CELLECTIS 3.240 € (+5,74 %)     COFACE 16.480 € (+0,24 %)     DANONE 61.680 € (-0,29 %)     AIR LIQUIDE 183.380 € (+1,66 %)     ASM INTERNATIONAL 906.400 € (+0,62 %)     BUREAU VERITAS 27.160 € (+0,97 %)     ING GROEP N.V. 27.085 € (+2,46 %)     CARREFOUR 17.180 € (+0,53 %)     BNP PARIBAS ACT.A 92.340 € (+2,68 %)     ADP 113.300 € (+3,75 %)     CROSSJECT 2.410 € (+7,11 %)     ATON 0.015 € (+2,82 %)     BRUNEL INTERNAT 7.590 € (-2,06 %)     GALP ENERGIA-NOM 18.810 € (-1,49 %)     LEGRAND 155.350 € (+1,80 %)     EUROFINS SCIENT. 62.860 € (+0,45 %)     AIR FRANCE -KLM 11.065 € (+7,90 %)     INPOST 15.360 € (+0,13 %)     L'OREAL 368.200 € (+1,81 %)     BOUYGUES 50.440 € (+2,25 %)     LVMH 478.750 € (+1,30 %)     ALFEN 18.400 € (+3,95 %)     ENGIE 27.360 € (+0,70 %)     REXEL 37.250 € (+1,53 %)     AEGON 7.572 € (+1,34 %)     SMCP 5.195 € (+2,77 %)     BE SEMICONDUCTOR 277.600 € (+1,46 %)     TOTALENERGIES 77.360 € (-1,64 %)     HERMES INTL 1 642.500 € (+2,34 %)     EUTELSAT COMMUNIC. 3.804 € (+0,21 %)     STELLANTIS NV 6.698 € (+2,87 %)     KALRAY 12.840 € (+16,09 %)     SAFRAN 301.600 € (+5,82 %)     SIGNIFY NV 20.640 € (+0,49 %)     THALES 231.500 € (+0,78 %)     UNIBAIL-RODAMCO-WE 98.880 € (+1,31 %)     DASSAULT SYSTEMES 20.540 € (+1,08 %)     SOCIETE GENERALE 71.490 € (+3,91 %)     STMICROELECTRONICS 57.020 € (-1,57 %)     KERING 247.350 € (+2,21 %)     RENAULT 28.960 € (+3,95 %)     FACEPHI 1.980 € (-5,71 %)     EUROAPI 1.496 € (-0,27 %)     CATANA GROUP 2.350 € (+2,62 %)     CATANA GROUP 2.350 € (+2,62 %)     ADYEN 983.400 € (+2,66 %)     PHARMING GROUP 1.189 € (+6,35 %)     HAFFNER ENERGY 0.232 € (+30,48 %)     ALSTOM 17.060 € (+1,10 %)     EXOSENS 64.700 € (+0,15 %)     IPSOS 37.400 € (+1,74 %)  
News Réglementées
08/05/2026 09:01

Original-Research: Scandinavian Astor Group AB (von NuWays AG): BUY

Original-Research: Scandinavian Astor Group AB - from NuWays AG

08.05.2026 / 09:01 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to Scandinavian Astor Group AB

Company Name:Scandinavian Astor Group AB
ISIN:SE0019175274
 
Reason for the research:Update
Recommendation:BUY
Target price:SEK 54
Target price on sight of:12 months
Last rating change:
Analyst:Simon Keller

NSG turns Astor into a scaled defence platform; PT Up

Astor delivered a strong Q1 and announced a transformative step to consolidate NSG, one of its best-performing assets. Overall, the developments highlight solid execution of the order book and strategic continuity under the incoming leadership.

Q1 26 sales rose 74% yoy to SEK 130m and EBITDA more than tripled to SEK 27.8m, implying a 21.4% margin, up 10.6pp yoy. The improvement was driven by better capacity utilisation, a stronger business mix and the SEK 5.6m at-equity contribution from NSG. Even excluding this at-equity result, the margin would have been at 17%, up 6.2pp yoy. Particularly strong was the Astor Industry segment. Sales grew 47% yoy to SEK 75.4m, EBITDA more than doubled to SEK 19.7m, courtesy of a c. 12pp margin improvement, supported by higher defence deliveries.

The acquisition of the remaining 63.5% of NSG looks transformative and should materially lift Astor’s scale, visibility and earnings base. NSG adds a highly relevant defence-infrastructure niche, offering classified high-security constructions such as shelters, secure data centres and containerised protection solutions against intrusion, sabotage and EMP risks. This fits squarely into Astor Protect, in our view.
  • The scale effect is substantial: based on a pro-forma Q1 calculation, group sales would rise by c. 80% to SEK 234m, EBITDA by c. 53% to SEK 42.7m, orders by c. 115% to SEK 194m and the order book by c. 110% to SEK 787m. NSG would therefore account for c. 44% of pro-forma sales, c. 48% of standalone EBITDA, c. 54% of orders and c. 52% of the combined order book.
  • Financing also looks manageable: Astor is paying SEK 295m in fixed cash/debt-like consideration. In addition, c. 8.8m new shares will be issued to the sellers, increasing the share count by c. 14%. A further earn-out of up to SEK 147m is linked to NSG’s 2027 EBITDA and therefore only becomes relevant if the asset performs.
  • Valuation looks attractive in light of the quality and growth profile. Astor is paying c. SEK 615m including the full earn-out for the acquired 63.5% stake, which corresponds to an acquired share of annualised Q1 EBITDA of SEK 52m (that is c. 12x price to acquired share of annualised EBITDA). Considering that the first stake in NSG was acquired significantly lower highlights Astor’s attractive M&A formula.
Meanwhile, Astor Protect, still largely driven by Ammunity, held up well sequentially, with sales almost flat qoq despite a seasonally strong Q4 base. With capex into new machinery at Ammunity set to lift production capacity from summer 2026, the segment should gain momentum over the coming quarters on a standalone basis as well.

In sum, the transaction is expected to be underlying margin-accretive and EPS-accretive. In our view, the deal materially strengthens the BUY case, as Astor is turning into a scaled listed European defence platform with a broader asset base, higher backlog visibility and stronger earnings capacity.

BUY, new PT SEK 54 (old: SEK 51), based on DCF and a peer group analysis.

You can download the research here: scandinavian-astor-group-ab-2026-05-08-previewreview-en-c4e15
For additional information visit our website: https://www.nuways-ag.com/research-feed

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2323672  08.05.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière